Search...
Jumpcan Pharma Gets Registration Certificate for Lidocaine Cataplasms
I'm PortAI, I can summarize articles.
(MT Newswires) -- Hubei Jumpcan Pharmaceutical (SHA:600566), through unit Shaanxi Dongke Pharmaceutical, obtained a drug registration certificate from the Chinese drug administration for its lidocaine cataplasms, according to a Shanghai bourse filing on Wednesday. The product is an amide local anesthetic that stabilizes nerve cell membranes. The certificate is valid until Sept. 8, 2030, the Chinese drug maker said.
Source: marketscreener The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments